Falck Medical, INC, an FDA registered
corporation, is a leading developer of innovative technologies
with applications in the diagnosis and treatment of ischemic
retinopathies, age related retinopathies and glaucoma. All of
the technologies are covered by multiple national/international
patents and patent pending applications.
To learn more about these innovative technologies please contact
us."Deus ex
Machina"
Scientific Advisory
Board Members:
Francis Y. Falck, Jr., MD, PhD, MS,
Assistant Clinical Professor, University of Connecticut School
of Medicine
David Epstein, MD, Professor and Chair, Department of
Ophthalmology, Duke University School of Medicine
Elias Reichel, MD, Vice Chairman, Department of Ophthalmology,
Tufts University School of Medicine
Research Presentations with Falck Medical, Inc
Technology:
Clinical
Comparison of the Falck Medical Tono-Ophthalmodynamometer (FAT
Model 1)
to Calibrated Weight Indentation Tonography. Agency for
Healthcare Research and Quality. Department of Health and Human
Services. Comparative Effectiveness of Screening for Glaucoma.
01/04/2011.
Clinical Comparison of the Falck Applanation Tonometer (FAT
Model 2) to Goldmann Applanation Tonometer. Agency for
Healthcare Research and Quality. Department of Health and Human
Services. Comparative Effectiveness of Treatment of Glaucoma.
01/04/2011.
Macular Society Meeting, 02/2010. Anti-VEGF Injections Decrease
Ocular Perfusion Pressure.
Association in Research in Vision and Ophthalmology Meeting,
05/2010. Anti-VEGF Injections and Ocular Perfusion Pressure.
World Forum 2010, Cambridge University, 08/2010. Strategies for
Preventing Blindness.
World Glaucoma Congress, Paris, France , 07/2011. Anti-VEGF
Injections Independently Increase Intraocular Pressure and
Decrease Ocular Perfusion Pressure.
Association for Research in Vision and Ophthalmology, 05/2000. Falck Medical Applanation Tonometer Intraocular Pressure
Measurements, Corneal Thickness and Corneal Curvature.
 Dr.
Francis Falck, Chief Executive Officer, Falck Medical, Inc
received the “2010 Man of the Year in Medicine and Healthcare
Award” at the World Forum 2010, Cambridge University, Cambridge,
England on August 18th, 2010.
Dr. Falck was recognized for his milestone work developing
diagnostic technology that will be used worldwide to prevent
blindness and stroke.
The World Forum 2010 was attended by 150 scholars from 40
different countries.
|
